Macro environment determinants affecting the availability of artemisinin-based combination therapies in Uganda

被引:0
|
作者
Oluka Nagitta, Pross [1 ]
Mkansi, Marcia [2 ]
机构
[1] Uganda Management Inst, Dept Econ & Managerial Sci, Kampala, Uganda
[2] Univ South Africa, Dept Operat Management, Pretoria, South Africa
关键词
Pharmaceutical supply chain; Political factors; Economic; Social-cultural; Legal; Technology; Developing countries; DEVELOPING-COUNTRIES; MALARIA; HEALTH; PROCUREMENT; MANAGEMENT; MEDICINE;
D O I
10.1108/IJPHM-09-2020-0074
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
PurposeArtemisinin-based combination therapies (ACTs) have been developed to treat uncomplicated malaria. However, scanty studies exist to inform the role of macro factors in explaining the nonavailability of ACT in developing countries. Therefore, this paper aims to evaluate the different macro-environment factors affecting the availability of ACTs in the public hospital setting. Design/methodology/approachThis study applied a quantitative methodological approach and structural equation modeling (SEM) to test hypotheses statistically. SEM examines linear causal relationships among variables while accounting for measurement error. Confirmatory factor analysis (CFA) was used to assess model reliability. CFA and SEM were used to determine the shared variance-covariance of variables, define the latent construct and provide a more precise way to account for the error variances associated with the variables, which, if untested, could lead to biased parameter estimates. This was guided by the data collected from 40 general public hospitals with 283 respondents. FindingsThis study's results support a model for promoting social-cultural, technological and legal factors. The availability of ACTs is significantly affected by legal factors. Improving legal aspects by a unit can enhance ACT availability by 0.59. Political factors scored the least, and they do not influence the availability of malaria drugs. Research limitations/implicationsThe design was quantitative and cross-sectional. Future research could be longitudinal with a mixed-method approach and consider other external stakeholders. Practical implicationsReducing the impact of the nonavailability of antimalarial drugs in general public hospitals requires a holistic concerted and coordinated supply chain approach that tackles the political, economic, social-cultural norms, technological and legal factors. Originality/valueThe authors develop and test a model using macro factors: political, economic, social, cultural, technological and legal factors. This model is relevant for many developing countries to supply chain coordination perpetually experiencing medicine shortages.
引用
收藏
页码:97 / 114
页数:18
相关论文
共 50 条
  • [1] Clinical pharmacology of artemisinin-based combination therapies
    Aweeka, Francesca T.
    German, Polina L.
    CLINICAL PHARMACOKINETICS, 2008, 47 (02) : 91 - 102
  • [2] Clinical Pharmacology of Artemisinin-Based Combination Therapies
    Francesca T. Aweeka
    Polina I. German
    Clinical Pharmacokinetics, 2008, 47 : 91 - 102
  • [3] Artemisinin-based combination therapies and their introduction in Japan
    Kano, Shigeyuki
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2010, 16 (06) : 375 - 382
  • [4] Artemisinin-based combination therapies for uncomplicated malaria
    Davis, TME
    Karunajeewa, HA
    Ilett, KF
    MEDICAL JOURNAL OF AUSTRALIA, 2005, 182 (04) : 181 - 185
  • [5] Study towards improving artemisinin-based combination therapies
    Lyu, Hai-Ning
    Ma, Nan
    Meng, Yuqing
    Zhang, Xing
    Wong, Yin-Kwan
    Xu, Chengchao
    Liao, Fulong
    Jiang, Tingliang
    Tu, Youyou
    Wang, Jigang
    NATURAL PRODUCT REPORTS, 2021, 38 (07) : 1243 - 1250
  • [6] Active Pharmacovigilance of Artemisinin-Based Combination Therapies in Benin
    Allabi, A. C.
    Kanmandozo, D.
    Massougbodji, A.
    DRUG SAFETY, 2013, 36 (09) : 819 - 820
  • [7] Misstatements in Artemisinin-Based Combination Therapies in Malaria Treatment
    Fleckenstein, Lawrence
    Miller, Robert M.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (10): : 1321 - 1322
  • [8] Plasmodium falciparum resistance to artemisinin-based combination therapies
    Ward, Kurt E.
    Fidock, David A.
    Bridgford, Jessica L.
    CURRENT OPINION IN MICROBIOLOGY, 2022, 69
  • [9] Are artemisinin-based combination therapies effective against Plasmodium malariae?
    Calleri, Guido
    Balbiano, Rosanna
    Caramello, Pietro
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (06) : 1447 - 1448
  • [10] Copayment mechanism in selected districts of Uganda: Availability, market share and price of quality assured artemisinin-based combination therapies in private drug outlets
    Ocan, Moses
    Nambatya, Winnie
    Otike, Caroline
    Nakalembe, Loyce
    Nsobya, Sam
    PLOS ONE, 2024, 19 (03):